<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03431727</url>
  </required_header>
  <id_info>
    <org_study_id>1-10-72-126-16</org_study_id>
    <nct_id>NCT03431727</nct_id>
  </id_info>
  <brief_title>Acromegaly - Before and After Treatment</brief_title>
  <official_title>Sleep Apnea, Circulation and Metabolism in Acromegaly - Before and After Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate sleep apnea, circulation and metabolism in acromegaly&#xD;
      before and after surgery and/or medical treatment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acromegaly is a rare disease caused by a growth hormone (GH) producing pituitary adenoma.&#xD;
      Surgery is primary treatment, whereas medical treatment with a somatostatin analogue (SA),&#xD;
      which suppresses GH secretion and reduces tumour size, is used when surgery is insufficient&#xD;
      or unfeasible. Acromegaly is associated with metabolic abnormalities which contributes to an&#xD;
      increased morbidity and mortality if left untreated. To which extend these abnormalities&#xD;
      reverses after treatment, and if treatment modality influences the outcome, remain elusive.&#xD;
      The aim of the study is to investigate sleep apnea, circulation and metabolism in acromegaly&#xD;
      before and after surgery and/or medical treatment&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sleep apnea</measure>
    <time_frame>At baseline (time of diagnosis) and at an average of 1 years treatment</time_frame>
    <description>ApneaLinkAir: respiratory effort, puls, oxygen saturation, nasal flow and snoring</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Circulation</measure>
    <time_frame>At baseline (time of diagnosis) and at an average of 1 years treatment</time_frame>
    <description>Sphygmocor: central arterial pressure and pulse wave velocity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bone metabolism</measure>
    <time_frame>At baseline (time of diagnosis) and at an average of 1 years treatment</time_frame>
    <description>HRpQCT scan</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heartfunction</measure>
    <time_frame>At baseline (time of diagnosis) and at an average of 1 years treatment</time_frame>
    <description>Echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Substrate metabolism; signaling proteins</measure>
    <time_frame>At baseline (time of diagnosis) and at an average of 1 years treatment</time_frame>
    <description>Western blotting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Substrate metabolism; gene targets</measure>
    <time_frame>At baseline (time of diagnosis) and at an average of 1 years treatment</time_frame>
    <description>qPCR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Energy expenditure</measure>
    <time_frame>At baseline (time of diagnosis) and at an average of 1 years treatment</time_frame>
    <description>Indirect calorimetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>At baseline (time of diagnosis) and at an average of 1 years treatment</time_frame>
    <description>DXA scan</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity</measure>
    <time_frame>At baseline (time of diagnosis) and at an average of 1 years treatment</time_frame>
    <description>Sensoriband</description>
  </secondary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Acromegaly</condition>
  <condition>Growth Hormone Treatment</condition>
  <condition>Sleep Apnea</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Bone Diseases</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples and tissue will be kept in a locked freezer thorughout the study period&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Newly diagnosed acromegalic patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Recently diagnosed with acromegaly&#xD;
&#xD;
          -  Age above 18&#xD;
&#xD;
          -  Written consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens Otto L Jørgensen, Porfessor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aarhus University Hospital, Department of internal medicine and endocrinology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mai C Arlien-Søborg, MD</last_name>
    <phone>+45 23837420</phone>
    <email>mas@clin.au.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jens Otto L Jørgensen, Professor</last_name>
    <phone>+45 24800664</phone>
    <email>joj@clin.au.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Aarhus University Hospital, Department of internal medicine and endocrinologi</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mai C Arlien-Søborg, MD</last_name>
      <phone>+45 23837420</phone>
      <email>mas@clin.au.dk</email>
    </contact>
    <investigator>
      <last_name>Jens Otto L Jørgensen, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mai C Arlien-Søborg, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 22, 2017</study_first_submitted>
  <study_first_submitted_qc>February 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 13, 2018</study_first_posted>
  <last_update_submitted>December 4, 2020</last_update_submitted>
  <last_update_submitted_qc>December 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acromegaly</mesh_term>
    <mesh_term>Bone Diseases</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

